oxyntomodulin has been researched along with Osteoarthritis* in 1 studies
1 other study(ies) available for oxyntomodulin and Osteoarthritis
| Article | Year |
|---|---|
The protective effects of dulaglutide against advanced glycation end products (AGEs)-induced degradation of type Ⅱ collagen and aggrecan in human SW1353 chondrocytes.
Osteoarthritis (OA) is one of the most prevalent degenerative joint diseases, and the risk of developing OA significantly increases with age as well as with concomitant diseases, such as diabetes. Advanced glycation end products (AGEs) accumulate in the body over time and are associated with increased expression of various molecules involved in the pathophysiology of OA. Prostaglandin E Topics: Aggrecans; Cell Line; Chemokines; Chondrocytes; Collagen Type II; Cytokines; Down-Regulation; Glucagon-Like Peptide-1 Receptor; Glucagon-Like Peptides; Glycation End Products, Advanced; Humans; Immunoglobulin Fc Fragments; Matrix Metalloproteinase 13; Matrix Metalloproteinase 3; NF-kappa B; Osteoarthritis; Oxidative Stress; Proteolysis; Reactive Oxygen Species; Recombinant Fusion Proteins | 2020 |